George Clinical has a dedicated global endpoint adjudication team that delivers end-to-end services ranging from study development and set-up through to study close. Using a validated web-based endpoint management system, George Clinical manages endpoint adjudication activities to the highest scientific and operational standards.
Specializing in cardiovascular and renal & metabolic endpoints, our endpoint adjudication team has managed the review of thousands of endpoints across a range of smaller outcomes trials to large, global, registration studies. Our team consists of medically trained people to provide leadership and medical oversight, and specialized operational people to ensure the study is optimally executed for effective endpoint collection and adjudication.
George Clinical has established endpoint adjudication committees of professorial industry leads across various therapeutic areas. Located at the best institutions across the globe, these adjudicators have extensive experience in adjudicating clinical endpoints, and often chair endpoint adjudication committees.
The endpoint adjudication team provides a variety of services including:
George Clinical’s preferred endpoint management system is IBM Clinical Development: a dedicated, web-based, commercial endpoint management system that is CFR 21 Part 11 compliant. This system provides an efficient, paper-less approach to the endpoint adjudication process. It enables us to centralize all endpoint documentation, track changes and manage new information. It allows us to closely monitor the endpoint adjudication workflow and ensures the timely delivery of the adjudication results.
George Clinical is dedicated to aligning with best industry practice, implements quality control activities across its adjudication projects, and monitors projects closely to enable continuous improvement to ensure projects are of the highest quality and delivered efficiently.